-+ 0.00%
-+ 0.00%
-+ 0.00%

Vaxcyte Q3 EPS $(1.56) Misses $(1.30) Estimate

Benzinga·11/04/2025 21:47:18
Listen to the news
Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(1.56) per share which missed the analyst consensus estimate of $(1.30) by 19.82 percent. This is a 87.95 percent decrease over losses of $(0.83) per share from the same period last year.